TECHNOLOGY TRANSFER OPPORTUNITY: Portable Slide Staining System for Microscopy (MSC-TOPS-132)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NASA MARSHALL SPACE FLIGHT CENTER

Contract Value

Not provided

Codes & Classification
Solicitation Number

T2P-JSC-00070

NAICS

927110 - Space Research and Technology

Classification Code

9999

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
NASA’s Technology Transfer Program is seeking expressions of interest from companies interested in obtaining license rights to commercialize, manufacture, and market an innovative Portable Slide Staining System for Microscopy (MSC-TOPS-132). This opportunity is being offered through a special notice (Procurement Identifier: T2P-JSC-00070) and is intended to facilitate the transfer of NASA-developed technology to the private sector for broader application and commercialization. The licensing rights may be granted on either an exclusive or nonexclusive basis and can be tailored to specific fields of use, depending on the applicant’s business objectives and capabilities. It is important to note that NASA does not provide funding in conjunction with these potential licenses. The technology in question was developed by innovators at NASA’s Johnson Space Center and is designed to support a range of applications, including medical diagnostics, research, and environmental monitoring. Originally deployed aboard the International Space Station to function in microgravity environments, the system is also suitable for terrestrial use in both field and laboratory settings. The core innovation lies in its fully self-contained, handheld design, which consists of two primary components: a dispenser with an adjustable reagent sponge delivery system, and a slide staining device that securely traps and seals the specimen slide. The dispenser is engineered to hold and deliver multiple uses of reagents, which can be replenished with commercially available solutions, while the slide staining device ensures precise application of reagents to the specimen. This system enables rapid, in situ microscopic analysis—critical in scenarios where returning samples to Earth is not feasible, such as diagnosing infections, conducting blood cell counts, determining platelet concentrations, or monitoring hematological effects of space events. The intended outcome of this procurement activity is to identify commercial partners capable of bringing this technology to market, thereby expanding its impact beyond NASA’s original mission requirements. Licensees will be expected to commercialize, manufacture, and distribute the technology, adapting it as needed for various applications in healthcare, research, or environmental monitoring. Key requirements for interested parties include submitting a license application through NASA’s Automated Technology Licensing Application System (ATLAS), accessible at https://technology.nasa.gov/patent/MSC-TOPS-132. All inquiries and questions should be directed to NASA’s Technology Transfer Program via email at [email protected], referencing the title of this Technology Transfer Opportunity and including preferred contact information. Additional information about NASA’s technology licensing process and other available technologies can be found at https://technology.nasa.gov/. This opportunity is classified under NAICS Code 927110 (Space Research and Technology, 2022 version) and Product Service Code 9999. The contracting entity is NASA Marshall Space Flight Center, operating under the National Aeronautics and Space Administration (NASA). The notice is currently active, with a response deadline of October 8, 2027. It is important for potential applicants to recognize that this is a technology transfer and licensing opportunity, not a procurement for goods or services. No set-aside requirements or follow-on procurement actions are anticipated as a result of responses to this notice. The primary objective is to gauge market interest and identify qualified licensees who can effectively commercialize the technology. Contractors evaluating this opportunity should consider their capabilities in product development, manufacturing, and commercialization of laboratory or medical diagnostic equipment, as well as their ability to navigate technology licensing agreements with federal agencies. The technology’s versatility and proven performance in challenging environments make it a strong candidate for adaptation to a wide range of commercial applications.